Chemanex PLC (CHMX)

Colombo

Currency in LKR

Disclaimer

82.00

+2.50(+3.14%)

Closed30/09

Fair Value

Day's Range

82.00

82.00

52 wk Range

64.00

91.00

CHMX Income Statement

Featured here, the Income Statement (earnings report) for Chemanex PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

395.85

441.4

639.68

1,063.65

788.97

Total Revenues Growth

-13.95%

+11.51%

+44.92%

+66.28%

-25.82%

Cost Of Revenues

313.28

337.92

473.35

665.83

600.4

Gross Profit

82.57

103.48

166.33

397.82

188.56

Gross Profit Growth

-8.67%

+25.31%

+60.74%

+139.18%

-52.6%

Gross Profit Margin %

20.86%

23.44%

26%

37.4%

23.9%

Other Operating Expenses, Total

91.43

57.21

61.2

127.8

62.68

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+16.14%	-37.42%	+6.97%	+108.83%	-50.95%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	96.56	71.12	87.16	154.83	91.32
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-5.13	-13.91	-25.96	-27.03	-28.64

Operating Income

-8.85

46.27

105.13

270.02

125.88

Operating Income Growth

-175.71%

+622.71%

+127.23%

+156.84%

-53.38%

EBIT Margin %

-2.24%

10.48%

16.43%

25.39%

15.95%

Net Interest Expenses

80.37

31.43

31.01

30.74

15.52

Net Interest Expenses Growth

+43.06%

-60.89%

-1.35%

-0.86%

-49.52%

Interest Expense, Total

-7.53

-6

-1.33

-13.87

-17.19

Interest And Investment Income

87.9

37.43

32.34

44.61

32.7

Other Non Operating Expenses, Total

8.75

-43.08

-17.7

-45.19

-0.22

EBT, Excl. Unusual Items

80.27

34.62

118.44

255.56

141.17

Gain (Loss) On Sale Of Assets

0

-

9.36

-

-

Other Unusual Items, Total

-

-

-

-

-

EBT, Incl. Unusual Items

237.29

34.62

127.8

255.56

141.17

EBT, Incl. Unusual Items Growth

+133.06%

-85.41%

+269.15%

+99.97%

-44.76%

EBT, Incl. Unusual Items Margin

59.94%

7.84%

19.98%

24.03%

17.89%

Income Tax Expense

10.18

15.47

30.45

85.7

29.34

Net Income to Company

229.33

23.53

111.8

177.55

111.35

Minority Interest

0.13

-

0.02

0.03

0.03

Net Income

229.46

23.53

111.83

177.58

111.38

Net Income Growth

+92.07%

-89.75%

+375.33%

+58.8%

-37.28%

Net Income Margin %

57.97%

5.33%

17.48%

16.7%

14.12%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

227.24

19.15

97.38

169.9

111.86

Basic EPS - Continuing Operations

14.47

1.22

6.2

10.82

7.12

Basic EPS - Continuing Operations Growth

+151.19%

-91.57%

+408.57%

+74.47%

-34.16%

Diluted EPS - Continuing Operations

14.47

1.22

6.2

10.82

7.12

Diluted EPS - Continuing Operations Growth

+151.19%

-91.57%

+408.57%

+74.47%

-34.16%

Basic Weighted Average Shares Outstanding

15.71

15.71

15.71

15.71

15.71

Diluted Weighted Average Shares Outstanding

15.71

15.71

15.71

15.71

15.71

Dividend Per Share

2

1

2

2.5

2.5

Dividend Per Share Growth

0%

-50%

+100%

+25%

0%

EBITDA

-8.59

46.28

105.36

270.69

127.91

EBITDA Growth

-168.09%

+638.94%

+127.66%

+156.92%

-52.75%

EBITDA Margin %

-2.17%

10.48%

16.47%

25.45%

16.21%

EBIT

-8.85

46.27

105.13

270.02

125.88

* In Millions of LKR (except for per share items)

25,037.55

+24.40

+0.10%

81,744.67

+109.86

+0.13%